PTH(1-84)/PTH(7-84): a balance of power.
This review considers many new basic and clinical aspects of parathyroid hormone (PTH). We focus especially on the identification of PTH fragments and how they may relate to renal failure, diagnosis, and treatment of secondary hyperparathyroidism and renal osteodystrophy. The biosynthesis and metabolism of PTH, measurement of circulating forms of PTH, the effects of PTH on receptor activation and turnover, the relationship between PTH levels and bone turnover in renal failure in humans, and the involvement of PTH in experimental models of renal failure are discussed. Despite these developments in understanding the etiology of renal failure and the availability of new assays for bioactive PTH, no adequate surrogate for bone biopsy and quantitative bone histomorphometry has been developed.
Friedman
Peter A
PA
Univ. of Pittsburgh School of Medicine, Dept. of Pharmacology, E-1347 Biomedical Science Tower, Pittsburgh, PA 15261, USA. paf10@pitt.edu
Goodman
William G
WG
D000595:Amino Acid Sequence; D000818:Animals; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology*; D004195:Disease Models, Animal; D015536:Down-Regulation; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications / Q000503:physiopathology*; D008962:Models, Theoretical; D008969:Molecular Sequence Data; D010281:Parathyroid Hormone / Q000096:biosynthesis / Q000502:physiology*; D051437:Renal Insufficiency / Q000503:physiopathology*
D010281:Parathyroid Hormone